China TCM (570.HK) - About the 25H1 Profit Warning and the Outlook
China TCM released weak 25H1 result,but it make investors reignite interest in betting on privatization/merger with Taiji.The Catalyst is CNPGC may...
659 Views
China Traditional Chinese Medicine (570 HK): Disaster as Offer Lapses, Potential Deal Break Price
This deal break caught many, including me, off guard. There are lessons to be learnt and questions to be asked. Shareholders will have a bruising...
1.5k Views
China Traditional Chinese Medicine (570.HK) - Will This Privatization Rumor Come True ?
We once again heard privatization rumor of China TCM.Considering the integration trend of SOE, privatization is always in the plan of CNPGC, but we...
695 Views
Primer: Chongqing Taiji Industry (Group) A (600129 CH) - Apr 2026
Chongqing Taiji Industry is a major Chinese pharmaceutical company specializing in both Traditional Chinese Medicine (TCM) and Western...
113 Views
The Concerns and Outlook About the Recent Rally in Traditional Chinese Medicine (TCM) Sector
The insight mainly analyzed the logic behind the recent rally in TCM sector, the policy impact, the concerns on limited resources, VBP,...
565 Views